Elevated glycosylated haemoglobin (HbA1c) is a risk marker in coronary artery bypass surgery

Scandinavian Cardiovascular Journal

Volumn 42, Issue 6, 2008, Pages 392-398

  Alserius, Thomas ^a,b   Anderson, Russell E ^a,b   Hammar, Niklas ^b   Nordqvist, Tobias ^b   Ivert, Torbjörn ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Coronary artery bypass; Diabetes mellitus; Mortality

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEMOGLOBIN DETERMINATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; WOUND INFECTION;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDIASTINITIS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STERNUM; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 57349124884     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430801942393     Document Type: Article

References (27)

1. Krishnamurti U, Steffes MW. Glycohemoglobin: A primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem. 2001;47:1157-65.
2. Anderson RE, Klerdal K, Ivert T, Hammar N, Barr G, Owall A. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? Eur Heart J. 2005;26:1513-8.
3. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet. 2002;359:2140-4.
4. Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144.
5. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-60 Discussion 36.
6. Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:77-81.
7. O'Sullivan CJ, Hynes N, Mahendran B, Andrews EJ, Avalos G, Tawfik S, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006;32:188-97.
8. Medhi M, Marshall MC, Burke HB, Hasan R, Nayak D, Reed G, et al. HbA1c predicts length of stay in patients admitted for coronary artery bypass surgery. Heart Dis. 2001;3:77-9.
9. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22:607-12.
10. de Vegt F, Dekker JM, Ruhé HG, Stehouwer CDA, Nijpels G, Bouter LM, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: The Hoorn Study. Diabetologia. 1999;8:926-31.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
12. Nashef SA, Roques F, Michel P, Cortina J, Faichney A, Gams E, et al. Coronary surgery in Europe: Comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardiothorac Surg. 2000;17:396-9.
13. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49:1711-21.
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
15. Arnqvist H, Wallensteen M, Jeppsson JO. Standardization of long term glucose measurements established. Lakartidningen. 1997;50:4789-90.
16. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem. 2004;50:166-74.
17. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;5:815-9.
18. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322:15-8.
19. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004;19:1175-80.
20. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405-12.
21. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350:2272-9.
22. Alserius T, Hammar N, Nordqvist T, Ivert T. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J. 2006;152:599-605.
23. Barsness GW, Peterson ED, Ohman EM, Nelson CL, De-Long ER, Reves JG, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 1997;96:2551-6.
24. Thourani VH, Weintraub WS, Stein B, Gebhart SS, Craver JM, Jones EL, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg. 1999;67:1045-52.
25. Corpus RA, O'Neill WW, Dixon SR, Timmis GC, Devlin WH. Relation of hemoglobin A1c to rate of major adverse cardiac events in nondiabetic patients undergoing percutaneous coronary revascularization. Am J Cardiol. 2003;92:1282-6.
26. Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis. 1987;156:967-73.
27. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH. Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. Circulation. 1995;92:2245-51.